TY - JOUR T1 - Fulminant myocarditis as an early presentation of SARS-CoV-2 JF - BMJ Case Reports JO - BMJ Case Reports DO - 10.1136/bcr-2020-237553 VL - 13 IS - 9 SP - e237553 AU - Tamara Naneishvili AU - Arsalan Khalil AU - Ryan O'Leary AU - Neeraj Prasad Y1 - 2020/09/01 UR - http://casereports.bmj.com/content/13/9/e237553.abstract N2 - Myocarditis is well known to be caused by viral infections such as Coxsackie virus group B, human herpes virus 6 and parvovirus B19. However, during the current emerging outbreak of SARS-CoV-2, there have been few case reports describing myocarditis as a possible presentation. In our case report we describe, early cardiac manifestations of SARS-CoV-2 in a UK District General Hospital. A 44-year-old Caucasian woman without any comorbidities presented with SARS-CoV-2 related fulminant myocarditis without initial respiratory symptoms. Patient underwent treatment with milrinone and methylprednisolone that showed reduction in myocardial inflammation and significantly improved myocardial contractility. This was then followed by a second phase of SARS-CoV-2 associated pneumonia and renal failure requiring ventilatory support and haemofiltration. Although, not described in the literature, we have found conjunctive use of milrinone and methylprednisolone effective in patient with SARS-CoV-2 fulminant myocarditis. ER -